Literature DB >> 10227125

Intracellular survival of virulent Mycobacterium bovis and M. bovis BCG in ferret macrophages.

M L Cross1, F E Aldwell, J F Griffin, C G Mackintosh.   

Abstract

The intracellular survival of virulent Mycobacterium bovis and avirulent M. bovis BCG in ferret alveolar macrophages was investigated. In addition, the effects of endogenous and exogenous modulators of macrophage oxidative function on bacterial survival and growth in vitro were determined. Ferret macrophages limited the initial growth of BCG, while virulent M. bovis replicated within macrophages. Intracellular bacterial survival was unaffected by the addition of specific inhibitors of macrophage oxidative function. A T-cell supernatant (TCS), derived from mitogen-stimulated lymphocyte cultures, activated ferret macrophages for heightened oxidative burst performance. However, macrophages activated by TCS, bacterial LPS or a combination of both, failed to control infection, and actually enhanced the intracellular survival of M. bovis. These results are discussed in relation to the role of macrophages in mediating tuberculosis-related pathogenesis, with respect to the fact that ferrets are important wildlife vectors of bovine tuberculosis in New Zealand.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227125     DOI: 10.1016/s0378-1135(99)00011-5

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  2 in total

1.  In vitro T-cell activation of monocyte-derived macrophages by soluble messengers or cell-to-cell contact in bovine tuberculosis.

Authors:  E Liebana; A Aranaz; M Welsh; S D Neill; J M Pollock
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

2.  Identifying Bacterial and Host Factors Involved in the Interaction of Mycobacterium bovis with the Bovine Innate Immune Cells.

Authors:  Federico Carlos Blanco; María José Gravisaco; María Mercedes Bigi; Elizabeth Andrea García; Cecilia Marquez; Mike McNeil; Mary Jackson; Fabiana Bigi
Journal:  Front Immunol       Date:  2021-07-15       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.